UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/300/0.01/18.06.25 Share Price

Warrant

D883T

DE000HC9RZW4

Real-time Euronext Paris 09:28:32 17/05/2024 BST
0.15 EUR -16.67% Intraday chart for UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/300/0.01/18.06.25
1 month-53.85%
3 months-57.14%
Date Price Change
17/05/24 0.15 -16.67%
16/05/24 0.18 -14.29%
15/05/24 0.21 +10.53%
14/05/24 0.19 +18.75%
13/05/24 0.16 -5.88%

Real-time Euronext Paris

Last update May 17, 2024 at 09:28 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer UniCredit UniCredit
D883T
ISINDE000HC9RZW4
Date issued 06/10/2023
Strike 300
Maturity 18/06/2025 (398 Days)
Parity 100 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.53
Lowest since issue 0.13
Spread 0.01
Spread %5.88%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
205.7 EUR
Average target price
251.3 EUR
Spread / Average Target
+22.18%
Consensus
  1. Stock Market
  2. Warrants
  3. D883T Warrant